Background Dostarlimab is a humanized monoclonal antibody that binds the programmed cell death protein 1 (PD-1) receptor and blocks interaction with its ligands PD-L1 and PD-L2. The GARNE...
BackgroundThe management of locally advanced rectal cancer (LARC) relies on a multimodal approach, including chemotherapy, radiation, and surgery. Neither instrumental work-up nor molecul...